Abstract
About this talk
The local production of active pharmaceutical ingredients (APIs) plays a vital role in strengthening national healthcare resilience by improving access to essential medicines and reducing dependence on imports and global supply chains. While the API industry is heavily driven by research, its growth is hindered by the lack of effective governance, insufficient support for R&D, regulatory gaps, and limited skilled workforce. These challenges create significant barriers to expanding local API manufacturing. This review explores the current pharmaceutical production landscape in Saudi Arabia, identifies key obstacles, and presents strategic solutions to enhance and diversify local API manufacturing.
Presentation Overview:
The presentation will examine the current state of API production in Saudi Arabia, the challenges impacting its growth, and strategic recommendations to strengthen and expand local pharmaceutical manufacturing.
Speaker
About the speaker
